Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|August 2, 2023
Case Report: Recurrent meningioma with multiple metastasesJuyue Zhou, Zhonghai Du
Frontiers in Oncology|July 4, 2024
Apatinib manifests an unexpectedly favorable outcome in the management of axillary lymph node follicular dendritic cell sarcoma: a case reportZhiying Feng, Zhonghai Du, Yan Liang, et al.
Critical Reviews in Oncology/Hematology|November 30, 2023
Benefits and risks of PD-1/PD-L1 inhibitors for recurrent small cell lung cancer: A systematic review and meta-analysisJuyue Zhou, Zhonghai Du, Yan Liang, et al.
Cancer Biomarkers : Section a of Disease Markers|March 9, 2017
MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistanceZhonghai Du, Shuxian Niu, Xiaoyu Xu, et al.
Frontiers in Immunology|March 24, 2023
Blood cell counts can predict adverse events of immune checkpoint inhibitors: A systematic review and meta-analysisJuyue Zhou, Zhonghai Du, Jie Fu, et al.
Frontiers in Oncology|January 7, 2025
Case report: Bone marrow metastasis and bone marrow necrosis occurring 11 years after ductal carcinoma <i>in situ</i> of the breastShuting Zhang, Zhonghai Du, Jun Wu, et al.
Medicine|December 10, 2025
A rare case of littoral cell angioma with paroxysmal nocturnal hemoglobinuriaZhenpeng Li, Sensen Zhang, Jun Wu, et al.
Autoimmunity|April 27, 2021
SChLAP1 contributes to non-small cell lung cancer cell progression and immune evasion through regulating the AUF1/PD-L1 axisZhonghai Du, Shuxian Niu, Juan Wang, et al.
Diagnostic Pathology|December 6, 2019
MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cellsZhonghai Du, Jun Wu, Juan Wang, et al.
BMC Medical Genomics|April 16, 2024
An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinomaZhonghai Du, Xiuchen Han, Liping Zhu, et al.
Pageof 2